Transient psychosis in women on clomiphene, bromocriptine, domperidone and related endocrine drugs

References

• Rachman M, Garfield DA, Rachman I, Cohen R. Lupron-induced mania. Biol Psychiatry 1999;45:243–4
   PubMed Web of Science ®Google Scholar
• Wahi MM, Skeate RC, Goldin SB, Santana CA. A second case report of leuprolide acetate for depot suspension-induced mania. CNS Spectr 2010;15:603–6
   PubMed Web of Science ®Google Scholar
• Warnock JK, Bundren JC. Anxiety and mood disorders associated with gonadotropin releasing hormone agonist therapy. Psychopharmacol Bull 1997;33:311–16
   PubMed Web of Science ®Google Scholar
• Mahe V, Nartowski J, Montagnon F, Dumaine A. Psychosis associated with gonadorelin agonist administration. Br J Psychiatry 1999;175:290–1
   PubMed Web of Science ®Google Scholar
• Chavez B, Reilly T. Manic and psychotic symptoms following subcutaneous leuprolide in a male patient with no prior psychiatric history. J Clin Psychiatry 2010;71:1696–8
   PubMed Web of Science ®Google Scholar
• Pong Y-H, Lu Y-C, Tsai VFS, et al. Acute manic and psychotic symptoms following subcutaneous leuprolide acetate in a male patient without prior psychiatric history:A case report and literature review. Urol Sci 2014;25:22–4
   Google Scholar
• Altmark D, Tomer R, Sigal M. Psychotic episode induced by ovulation-initiating treatment. Israel J Med Sci 1987;23:1156–7
   PubMedGoogle Scholar
• Cashman FE, Sheppard R. Clomiphene citrate as a possible cause of psychosis. Can Med Assoc J 1982;126:118
   PubMed Web of Science ®Google Scholar
• Holka-Pokorska J, Piróg-Balcerzak A, Stefanowic A. Mid-stimulation psychosis in the course of in vitro fertilization procedure with the use of clomiphene citrate and bromocriptine – case study. Psychiatr Pol 2014;48:901–16
   PubMed Web of Science ®Google Scholar
• Kapfhammer HP, Messer T, Hoff P. Psychotic illness during treatment with clomifen. Dtsch Med Wochenschr 1990;115:936–9
   PubMed Web of Science ®Google Scholar
• Siedentopf F, Horstkamp B, Stief G, Kentenich H. Clomiphene citrate as a possible cause of a psychotic reaction during infertility treatment. Hum Reprod 1997;12:706–7
   PubMed Web of Science ®Google Scholar
• Volgsten H, Skoog Svanberg A, Ekselius L, et al. Prevalence of psychiatric disorders in infertile women and men undergoing in vitro fertilization treatment. Hum Reprod 2010;23:2056–63
   Web of Science ®Google Scholar
• Mahé V, Dumaine A. Oestrogen withdrawal associated psychoses. Acta Psychiatr Scand 2001;104:323–31
   PubMed Web of Science ®Google Scholar
• Bergemann N, Parzer P, Runnebaum B, et al. Estrogen, menstrual cycle phases and psychopathology in women suffering from schizophrenia. Psychol Med 2007;37:1427–36
   PubMed Web of Science ®Google Scholar
• Huber TJ, Borsutzky M, Schneider U, Emrich HM. Psychotic disorders and gonadal function: evidence supporting the oestrogen hypothesis. Acta Psychiatr Scand 2004;109:269–74
   PubMed Web of Science ®Google Scholar
• Seeman MV. Menstrual exacerbation of schizophrenia symptoms. Acta Psychiatr Scand 2012;125:363–71
   PubMed Web of Science ®Google Scholar
• Bergink V, Lambregtse-van den Berg MP, Koorengevel KM, et al. First-onset psychosis occurring in the postpartum period: a prospective cohort study. J Clin Psychiatry 2011;72:1531–7
   PubMed Web of Science ®Google Scholar
• Sit D, Rothschild AJ, Wisner KL. A review of postpartum psychosis. J Womens Health [Larchmont] 2006;15:352–68
   PubMed Web of Science ®Google Scholar
• Brockington IF. Post-abortion psychosis. Arch Women’s Mental Health 2005;8:53–4
   PubMed Web of Science ®Google Scholar
• Chandra PS. Post-ovariectomy and oestrogen therapy related recurrence of oestrogen withdrawal associated psychosis. Acta Psychiatr Scand 2002;106:76–7
   PubMed Web of Science ®Google Scholar
• Robinson GE. Psychotic and mood disorders associated with the perimenopausal period. CNS Drugs 2001;15:175–84
   PubMed Web of Science ®Google Scholar
• Huber TJ, Nickel V, Troger M, et al. A syndrome of psychosis following discontinuation of an estrogen-progestogen contraceptive and improvement following replacement: a case report. Neuropsychobiology 1999;40:75–7
   PubMed Web of Science ®Google Scholar
• Findley JC, Joshi KG. A case of repeated brief psychotic episodes secondary to discontinuation of non-prescription estrogen replacement therapy. Psychosomatics 2012;53:285–8
   PubMed Web of Science ®Google Scholar
• Summers SM, Onate J. New onset psychosis following abrupt discontinuation of hormone replacement therapy in a trans woman. J Gay and Lesbian Mental Health 2014;18:312–19
   Google Scholar
• Barth C, Villringer A, Sacher, J. Sex hormones affect neurotransmitters and shape the adult female brain during hormonal transition periods. Front Neurosci 2015;9:37
   PubMed Web of Science ®Google Scholar
• Di Paolo T. Modulation of brain dopamine transmission by sex steroids. Rev Neurosci 1994;5:27–41
   PubMedGoogle Scholar
• Siedentopf F, Kentenich H. Future use of clomiphene in ovarian stimulation. Psychic effects of clomiphene citrate. Hum Reprod 1998;13:2986–7
   PubMed Web of Science ®Google Scholar
• Bilal L, Ching C. Cabergoline-induced psychosis in a patient with undiagnosed depression. J Neuropsychiatry Clin Neurosci 2012;2:E54
   Google Scholar
• Boyd A. Bromocriptine and psychosis: a literature review. Psychiatr Q 1995;66:87–95
   PubMed Web of Science ®Google Scholar
• Cabeza GA, Flores LF, Iñigues IE, Valencia PF. Acute psychosis secondary to bromocriptine treatment in a patient with a prolactinoma. Rev Invest Clin 1984;36:147–9
   PubMed Web of Science ®Google Scholar
• Dorevitch A, Aronzon R, Stark M. Psychotic exacerbation attributed to low-dose bromocriptine treatment of galactorrhea and hyperprolactinemia. Acta Obstet Gynecol Scand 1991;70:375–6
   PubMed Web of Science ®Google Scholar
• Einarson TR, Turchet EN. Psychotic reaction to low-dose bromocriptine. Clin Pharm 1982;2:273–4
   Google Scholar
• Le Feuvre CM, Isaacs AJ, Frank OS. Bromocriptine-induced psychosis in acromegaly. Br Med J 1982;285:1315
   PubMed Web of Science ®Google Scholar
• Peter SA, Autz A, Jean-Simon ML. Bromocriptine-induced schizophrenia. J Natl Med Assoc 1993;85:700–1
   PubMed Web of Science ®Google Scholar
• Procter AW, Littlewood R, Fry AH. Bromocriptine induced psychosis in acromegaly. Br Med J 1983;286:50–1
   PubMedGoogle Scholar
• Serby M, Angrist B, Lieberman A. Mental disturbances during bromocriptine and lergotrile treatment of Parkinson’s disease. Am J Psychiatry 1978;135:1227–9
   PubMed Web of Science ®Google Scholar
• Shukla S, Turner WJ, Newman G. Bromocriptine-related psychosis and treatment. Biol Psychiatry 1985;20:326–8
   PubMed Web of Science ®Google Scholar
• Taneli B, Ozaskinli S, Kirli S, et al. Bromocriptine-induced schizophrenic syndrome. Am J Psychiatry 1986;143:935
   PubMed Web of Science ®Google Scholar
• Turner TH, Cookson JC, Wass JA, et al. Psychotic reactions during treatment of pituitary tumors with dopamine agonists. Br Med J 1984;289:1101–3
   PubMed Web of Science ®Google Scholar
• Wang F, Zheng S, Zhang Y. Serious bromocriptine-induced psychosis: suicide in the treatment of prolactinoma. Neurosurg Q 2013;23:249–51
   Web of Science ®Google Scholar
• Canterbury RJ, Haskins B, Kahn N, et al. Postpartum psychosis induced by bromocriptine. South Med J 1987;80:1463–4
   PubMed Web of Science ®Google Scholar
• Iffy L, Lindenthal J, Szodi Z, Griffin W. Puerperal psychosis following ablactation with bromocriptine. Med Law 1989;8:171–4
   PubMedGoogle Scholar
• Kemperman CJF, Zwanikken GJ. Psychiatric side effects of bromocriptine therapy for postpartum galactorrhoea. J R Soc Med 1987;80:387–8
   PubMed Web of Science ®Google Scholar
• Pinkofsky HB, Reeves RR. Postpartum psychosis induced by bromocriptine and pseudoephedrine. J Fam Pract 1997;45:164–6
   PubMed Web of Science ®Google Scholar
• Ecker D, Unrath A, Kassubek J, Sabolek M. Dopamine agonists and their risk to induce psychotic episodes in Parkinson’s disease: a case–control study. BMC Neurol 2009;9:23
   PubMed Web of Science ®Google Scholar
• Seeman P, Lee T. Antipsychotic drugs: direct correlation between clinical potency and presynaptic action on dopamine neurons. Science 1975;188:1217–19
   PubMed Web of Science ®Google Scholar
• Godar SC, Bortolato M. Gene-sex interactions in schizophrenia: focus on dopamine neurotransmission. Front Behav Neurosci 2014;8:71
   PubMed Web of Science ®Google Scholar
• Fournié A, Graille V, Montastruc JL. [Bromocriptine, lactation inhibition and drug monitoring]. J Gynecol Obstet Biol Reprod 1994;23:129–30
   PubMedGoogle Scholar
• Morgans D. Bromocriptine and post-partum lactation suppression. Br J Obstet Gynecol 1995;102:851–3
   PubMedGoogle Scholar
• Rayburn WE. Clinical commentary: the bromocriptine [Parlodel] controversy and recommendations for lactation suppression. Am J Perinatol 1996;13:69–71
   PubMed Web of Science ®Google Scholar
• Laduron PM, Leysen JE. Domperidone, a specific in vitro dopamine antagonist, devoid of in vivo central dopaminergic activity. Biochem Pharmacol 1979;28:2161–5
   PubMed Web of Science ®Google Scholar
• Barone JA. Domperidone: a peripherally acting dopamine2-receptor antagonist. Ann Pharmacother 1999;33:429–40
   PubMed Web of Science ®Google Scholar
• Papastergiou J, Abdallah M, Tran A, Folkins C. Domperidone withdrawal in a breastfeeding woman. Can Pharm Jl 2013;146:210–12
   Google Scholar
• Roy-Desruisseaux J, Landry J, Bocti C, et al. Domperidone-induced tardive dyskinesia and withdrawal psychosis in an elderly woman with dementia. Ann Pharmacother 2011;45:e51
   PubMedGoogle Scholar
• (a) Seeman P. Yes, breast is best but taper domperidone when stopping. Br J Gen Pract 2014;64:618. (b) Chouinard G, Chouinard VA. Atypical antipsychotics: CATIE study, drug-induced movement disorder and resulting iatrogenic psychiatric-like symptoms, supersensitivity rebound psychosis and withdrawal discontinuation syndromes. Psychother Psychosom 2008;77:69–77
   Google Scholar
• Fallon P, Dursun SM. A naturalistic controlled study of relapsing schizophrenic patients with tardive dyskinesia and supersensitivity psychosis. J Psychopharmacol 2011;25:755–62
   PubMed Web of Science ®Google Scholar
• Moncrieff J. Does antipsychotic withdrawal provoke psychosis? Review of the literature on rapid onset psychosis [supersensitivity psychosis] and withdrawal-related relapse. Acta Psychiatr Scand 2006;114:3–13
   PubMed Web of Science ®Google Scholar
• Hochberg Z, Pacak K, Chrousos GP. Endocrine withdrawal syndromes. Endocrine Rev 2013;24:523–38
   Google Scholar
• Fink G, Sumner BE, McQueen JK, et al. Sex steroid control of mood, mental state and memory. Clin Exp Pharmacol Physiol 1998;25:764–75
   PubMed Web of Science ®Google Scholar
• Sumner BE, Fink G. Effects of acute estradiol on 5-hydroxytryptamine and dopamine receptor subtype mRNA expression in female rat brain. Mol Cell Neurosci 1993;4:83–92
   PubMed Web of Science ®Google Scholar
• Kabelik D, Schrock SE, Ayres LC, et al. Estrogenic regulation of dopaminergic neurons in the opportunistically breeding zebra finch. Gen Comp Endocrinol 2011;173:96–104
   PubMed Web of Science ®Google Scholar
• Sánchez MG, Bourque M, Morissette M, Di Paolo T. Steroids-dopamine interactions in the pathophysiology and treatment of CNS disorders. CNS Neurosci Ther 2010;16:e43–71
   PubMed Web of Science ®Google Scholar
• Novella S, Dantas AP, Segarra G, et al. Vascular aging in women: is estrogen the fountain of youth? Front Physiol 2012;3:165
   PubMed Web of Science ®Google Scholar
• Prossnitz ER, Barton M. The G-protein-coupled estrogen receptor GPER in health and disease. Nat Rev Endocrinol 2011;7:715–26
   PubMed Web of Science ®Google Scholar
• Yildiz-Unal A, Korulu S, Karabay A. Neuroprotective strategies against calpain-mediated neurodegeneration. Neuropsychiatr Dis Treat 2015;11:297–310
   PubMed Web of Science ®Google Scholar
• Deuchar N, Brockington I. Puerperal and menstrual psychoses: the proposal of a unitary etiological hypothesis. J Psychosom Obstet Gynaecol 1998;19:104–10
   PubMed Web of Science ®Google Scholar
• Min JA, Kim JJ, Pae CU, et al. Association of estrogen receptor genes and schizophrenia: a preliminary study. Prog Neuropsychopharmacol Biol Psychiatry 2012;36:1–4
   PubMed Web of Science ®Google Scholar
• Wang S, Li W, Zhao J, et al. Association of estrogen receptor alpha gene polymorphism with age at onset, general psychopathology symptoms, and therapeutic effect of schizophrenia. Behav Brain Funct 2013;9:12
   PubMed Web of Science ®Google Scholar
• Weickert CS, Miranda-Angulo AL, Wong J, et al. Variants in the estrogen receptor alpha gene and its mRNA contribute to risk for schizophrenia. Hum Mol Genet 2008;17:2293–309
   PubMed Web of Science ®Google Scholar
• Madularu D, Shams WM, Brake WG. Estrogen potentiates the behavioral and nucleus accumbens dopamine response to continuous haloperidol treatment in female rats. Eur J Neurosci 2014;39:257–65
   PubMed Web of Science ®Google Scholar
• Lévesque D, Di Paolo T. Rapid conversion of high into low striatal D2-dopamine receptor agonist binding states after an acute physiological dose of 17 beta-estradiol. Neurosci Lett 1988;88:113–18
   PubMed Web of Science ®Google Scholar